	Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment. J Clin Invest Young KS, Fanning SW. PMID: 42878076 [PubMed - as supplied by publisher]
	PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance. J Clin Invest Napolitano F, Unni N, Arteaga CL. PMID: 42878075 [PubMed - as supplied by publisher]
	Next-generation CDK inhibitors in HR+/HER2- breast cancer. J Clin Invest Seriak D, Kim JY, Shapiro GI, Giordano A. PMID: 42878072 [PubMed - as supplied by publisher]
	The Impact of Assisted Reproduction Technology on Breast Cancer Risk for Women With Infertility: Current Insights and Future Perspectives. Cureus Bimpa K, Xydias EM, Varvaras D, Koronarchis DN, Tsakos E. PMID: 42877633 [PubMed]
	Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model. Front Public Health Jin S, Ma X, Yang X, Zhang W, Li H, Gu Y, Wu B. PMID: 42877267 [PubMed - indexed for MEDLINE]
	Exploring adapted water polo: a feasibility study on improving psychosocial recovery in women post-breast cancer treatment. Front Sports Act Living Cuvelier S, Goetgheluck-Villaron C, Zemmour C, Bernasconi S, Tallet A, Arthur A, Dantin P, Viens P, Cohen M, Calvin S. PMID: 42876842 [PubMed]
	The mediating role of perceived spousal support in the association between psychological crisis and psychological distress among breast cancer patients and their spouses: a longitudinal study based on an actor-partner interdependence mediation model with cross-lagged analysis. Front Public Health Yu X, Ding Y, Wang Z, Wang H, Ming Z, Ni X, Yu Y. PMID: 42876596 [PubMed - indexed for MEDLINE]
	From PDTA to PIDTA: a new integrated care pathway to improve survival and quality of life in breast cancer patients. Minerva Surg Franceschini G, Magno S. PMID: 42876343 [PubMed - indexed for MEDLINE]
	Machine learning predictors of post-radiotherapy cardiotoxicity in a Latin American breast cancer cohort: Clinical risk factors outperform cardiac dosimetry. J Appl Clin Med Phys Aguirre-Bravo V, El Far R, Herrera Ruiz M, Gálvez Santelices S, Munoz-Schuffenegger P, Merino T, Diez Domingo S, Andia ME. PMID: 42876042 [PubMed - indexed for MEDLINE]
	Primary Intermammary Breast Carcinoma Presenting With Direct Sternal Invasion: A Diagnostic Pitfall of Standard Screening Mammography. Am J Case Rep Deming R, Fei M, Pudhota HC, Haerter SP, Hazin M. PMID: 42876016 [PubMed - indexed for MEDLINE]
	Prediction of radiation-induced hypothyroidism after proton-based supraclavicular nodal irradiation in breast cancer. Med Phys Sun J, Li P, Hao Y, Sheng Y, Wang W, Zhang Q, Guo X. PMID: 42875928 [PubMed - indexed for MEDLINE]
	Machine learning model for the prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer. BMC Cancer Reisig E, Cai L, Müller M, Schäfgen B, Pfob A. PMID: 42875758 [PubMed - indexed for MEDLINE]
	Experiential Support Across Breast Cancer Care and Familial Breast Cancer Genetic Risk Assessment in Quebec, Canada: A Comparative Study of Accompanying Patients' Contributions. J Cancer Educ Bouchard K, Dorval M, Bélanger L, Chiquette J, Côté M, Vialaron C, Normandin L, Iliescu Nelea M, Ahmed AB, Pomey MP. PMID: 42875714 [PubMed - as supplied by publisher]
	Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches. J Steroid Biochem Mol Biol Di Y, Hu X, Dai J, Rajalakshmi K, Arulsamy S, Kiruthiga N, Theivendren P, Muthusamy S, Zhu D. PMID: 42874789 [PubMed - as supplied by publisher]
	Proton Therapy for Breast, Prostate, and Leptomeningeal Disease-Some Answers, but Questions Persist. Int J Radiat Oncol Biol Phys Narra LR, Dess RT, Anderson B, Kim MM, Jabbour SK. PMID: 42874645 [PubMed - in process]
	Effect of electromagnetic waves from doxorubicin on breast cancer growth in a mouse model. Cancer Treat Res Commun Al-Ghamdi FH, Abou Al-Saud S, AlShammari HF, Binobaid L, Almousa R. PMID: 42874442 [PubMed - as supplied by publisher]
	Survival and disease burden of breast cancer (Monastir, Tunisia): A population-based cohort study (2002-2022). PLoS One Zemni I, Maatouk A, Boufrikha W, Bennasrallah C, Dhouib W, Kacem M, Abroug H, Ben Fredj M, Bouanene I, Jridi I, Arfa H, Ben Salem A, Njim L, Zaied S, Faleh R, Sakka K, Sriha B, Jaîdane L, Mehdi M, Belguith Sriha A. PMID: 42873796 [PubMed - indexed for MEDLINE]
	A randomized phase II study of fulvestrant with or without ganetespib in patients with endocrine resistant metastatic breast cancer. Oncologist Grinshpun A, Waks AG, Fu J, Kurnia P, Guo H, Li T, Moore M, DiLullo M, Patel A, Whitesell L, Atanasov S, Partridge AH, Mayer EL, Krop IE, Santagata S, Brown M, Winer EP, Reeder-Hayes K, Anders C, Jeselsohn R, Lin NU. PMID: 42873573 [PubMed - as supplied by publisher]
	Beyond demographics: physical activity as a key behavioral marker for identifying the guidance-seeking profile to guide precision survivorship care. Support Care Cancer Yao Y, Xiao R, Cheng Q, Lei X, Wu H, Liu X. PMID: 42873292 [PubMed - indexed for MEDLINE]
	Neutrophil Extracellular Traps as Predictive Biomarkers in Trastuzumab-Treated HER2-Positive Breast Cancer: A Prospective Cohort Study. J Vis Exp Wang Y, Wang L, Zhao L, Zhou L, Chen H, Zhang Y, Liu S, Zhu T. PMID: 42872727 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 223050

Page 1 of 11153



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy